In collaboration with The Dedham Group, Click Therapeutics Chief Strategy Officer, Austin Speier, and Director of Strategy, Steven L., share an overview of the FDA Prescription Drug Use-Related Software (PDURS) draft guidance, outlining the key differences from previous digital health opportunities and how this draft guidance could drive better health outcomes for patients. Learn more about this new regulatory pathway for integrating software with existing drug products here: https://lnkd.in/eYAX3vYN
The FDA’s guidance on Regulatory Considerations for Prescription Drug Use-Related Software (PDURS) opens up opportunities for brand differentiation and commercial success in pharma. https://ow.ly/VqV050SPoQF The Dedham Group’s Manuel Jurado, with Austin Speier and Steven L. of Click Therapeutics, Inc. write about how pharma manufacturers can prepare for PDURS guidance and capitalize on these opportunities. Read the article for more.